What can an MRI contribute in the biochemically recurrent setting? MRI may be of value in cases of PSMA-negative recurrences. Approximately 12% of patients harbor PSMA-negative tumors (i.e., % ...
Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback